Search research articles
Contact Us
Filters
Showing results (801-810 of 839) with videos related to
Page
of 84
Sort By:
NPJ Precision Oncology
|
October 1, 2024
The role of TERT C228T and KDM6A alterations and TME in NMIBC treated with BCG
Qi-Dong Xia, Jian-Xuan Sun, Zhi-Peng Yao, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
July 15, 2017
Role of quantitative hepatitis B core antibody levels in predicting significant liver inflammation in chronic hepatitis B patients with normal or near-normal alanine aminotransferase levels
Jing Li, Tian-Ying Zhang, Liu-Wei Song, et al.
Science Bulletin
|
January 7, 2024
PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): A phase 2, randomized, controlled trial
Si-Yang Maggie Liu, Jie Huang, Jia-Yi Deng, et al.
Journal of Nanobiotechnology
|
November 20, 2024
Mechanism of cold exposure delaying wound healing in mice
Fu-Xing-Zi Li, Jun-Jie Liu, Li-Min Lei, et al.
Journal of Nanobiotechnology
|
June 24, 2026
Cold exposure-induced loss of beneficial gut bacterial sEV is associated with the pathogenesis of bone loss through pyroptosis pathway
Li-Min Lei, Xiao Lin, Feng Xu, et al.
The Lancet. Oncology
|
December 14, 2011
Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial
Lei Chen, Chao-Su Hu, Xiao-Zhong Chen, et al.
Molecular Oncology
|
April 20, 2023
Genomic and immune characteristics of HER2-mutated non-small-cell lung cancer and response to immune checkpoint inhibitor-based therapy
Hai-Yan Tu, Kai Yin, Xiaotian Zhao, et al.
The Lancet. Oncology
|
December 9, 2025
Vebreltinib in MET amplification-driven advanced non-small-cell lung cancer (KUNPENG): a single-arm, multi-cohort, multicentre, phase 2 study
Yi-Long Wu, Yu Yao, Jin-Ji Yang, et al.
Signal Transduction and Targeted Therapy
|
February 23, 2023
Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non-small-cell lung cancer: final overall survival analysis of the EMERGING-CTONG 1103 randomised phase II trial
Wen-Zhao Zhong, Hong-Hong Yan, Ke-Neng Chen, et al.
Journal of Nanobiotechnology
|
June 23, 2024
Cold exposure-induced plasma exosomes impair bone mass by inhibiting autophagy
Li-Min Lei, Fu-Xing-Zi Li, Xiao Lin, et al.
Page
of 84
Search research articles
Search
Showing results (801-810 of 839) with videos related to
Sort By:
Page
of 84
NPJ Precision Oncology
|
October 1, 2024
The role of TERT C228T and KDM6A alterations and TME in NMIBC treated with BCG
Qi-Dong Xia, Jian-Xuan Sun, Zhi-Peng Yao, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
July 15, 2017
Role of quantitative hepatitis B core antibody levels in predicting significant liver inflammation in chronic hepatitis B patients with normal or near-normal alanine aminotransferase levels
Jing Li, Tian-Ying Zhang, Liu-Wei Song, et al.
Science Bulletin
|
January 7, 2024
PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): A phase 2, randomized, controlled trial
Si-Yang Maggie Liu, Jie Huang, Jia-Yi Deng, et al.
Journal of Nanobiotechnology
|
November 20, 2024
Mechanism of cold exposure delaying wound healing in mice
Fu-Xing-Zi Li, Jun-Jie Liu, Li-Min Lei, et al.
Journal of Nanobiotechnology
|
June 24, 2026
Cold exposure-induced loss of beneficial gut bacterial sEV is associated with the pathogenesis of bone loss through pyroptosis pathway
Li-Min Lei, Xiao Lin, Feng Xu, et al.
The Lancet. Oncology
|
December 14, 2011
Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial
Lei Chen, Chao-Su Hu, Xiao-Zhong Chen, et al.
Molecular Oncology
|
April 20, 2023
Genomic and immune characteristics of HER2-mutated non-small-cell lung cancer and response to immune checkpoint inhibitor-based therapy
Hai-Yan Tu, Kai Yin, Xiaotian Zhao, et al.
The Lancet. Oncology
|
December 9, 2025
Vebreltinib in MET amplification-driven advanced non-small-cell lung cancer (KUNPENG): a single-arm, multi-cohort, multicentre, phase 2 study
Yi-Long Wu, Yu Yao, Jin-Ji Yang, et al.
Signal Transduction and Targeted Therapy
|
February 23, 2023
Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non-small-cell lung cancer: final overall survival analysis of the EMERGING-CTONG 1103 randomised phase II trial
Wen-Zhao Zhong, Hong-Hong Yan, Ke-Neng Chen, et al.
Journal of Nanobiotechnology
|
June 23, 2024
Cold exposure-induced plasma exosomes impair bone mass by inhibiting autophagy
Li-Min Lei, Fu-Xing-Zi Li, Xiao Lin, et al.
Page
of 84